Gabapentin for inflammation
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Anti-Inflammatory Effects: Mechanisms and Evidence
Gabapentin Reduces Inflammation in Animal Models
Gabapentin, commonly known for its use in neuropathic pain and as an anticonvulsant, has shown significant anti-inflammatory effects in various animal models. Studies in mice and rats demonstrate that gabapentin reduces inflammation by lowering levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, as well as decreasing oxidative stress markers like malondialdehyde (MDA) and increasing antioxidant glutathione (GSH) levels Dias2014Motavallian2021. In models of colitis, gabapentin treatment led to reduced macroscopic and microscopic lesions, decreased myeloperoxidase (MPO) activity, and improved histopathological outcomes, suggesting its potential as a therapeutic agent for inflammatory bowel diseases De Brito2020Motavallian2021.
Mechanisms: PPAR-gamma Activation and NF-κB Inhibition
Gabapentin’s anti-inflammatory action is closely linked to the activation of the peroxisome proliferator-activated receptor gamma (PPAR-γ) pathway. Activation of PPAR-γ by gabapentin inhibits the nuclear factor kappa B (NF-κB), a key regulator of inflammatory gene expression. This results in reduced production of inflammatory mediators and enzymes such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) De Brito2020Li2024. The anti-inflammatory effects of gabapentin are diminished when PPAR-γ is inhibited, highlighting the importance of this pathway De Brito2020Li2024.
Gabapentin in Specific Inflammatory Conditions
Intestinal and Cardiac Inflammation
In experimental colitis, gabapentin not only reduced inflammation but also regulated mast cell signaling and oxidative stress De Brito2020Motavallian2021. In cardiac inflammation following myocardial infarction, gabapentin shifted macrophage polarization from the pro-inflammatory M1 type to the anti-inflammatory M2 type, reduced fibrosis, and improved cardiac function, again through PPAR-γ activation .
Ocular and Airway Inflammation
Gabapentin has also been shown to reduce ocular inflammation in rabbit models by decreasing cytokine production and COX-2 expression, suggesting its potential for treating inflammatory eye conditions like uveitis . In a mouse model of allergic asthma, gabapentin reduced lung inflammation, decreased levels of TNF-α, IL-4, and IL-13, and improved antioxidant status, indicating benefits in airway inflammatory diseases .
Synergistic and Derivative Approaches
Combining gabapentin with other analgesics, such as nefopam, has produced synergistic anti-inflammatory and anti-nociceptive effects in models of inflammatory, osteoarthritis, and neuropathic pain, allowing for lower effective doses and fewer side effects . Additionally, derivatives of gabapentin, such as gabapentsal, and conjugates with NSAIDs have shown promising anti-inflammatory and antipyretic properties in preclinical studies Ahmad2021Rabee2025.
Human Studies: Limited but Suggestive Evidence
In human studies, gabapentin has shown some ability to reduce primary mechanical allodynia in acute inflammatory pain models, though its effects on other pain and inflammation measures were less pronounced. These findings suggest a potential, but not yet fully established, role for gabapentin in managing acute inflammatory pain in humans .
Conclusion
Gabapentin demonstrates clear anti-inflammatory effects in a variety of animal models, acting through PPAR-γ activation and NF-κB inhibition, and reducing key inflammatory mediators and oxidative stress. Its benefits extend to intestinal, cardiac, ocular, and airway inflammation, and it may work synergistically with other drugs. While evidence in humans is still limited, these findings support further investigation of gabapentin as a potential anti-inflammatory therapy.
Sources and full results
Most relevant research papers on this topic